Notice ID: 113755233be74b95b506ecad7255f299Combined Synopsis/Solicitation
3D Liver Microstissues Composed of Human Primary Hepatocytes and a Mixture of Human Primary Hepatocyte, Liver Endothelial Cells and Kupffer Cells
Archived on May 15, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM UTC−04:00
- Posted
- May 10, 2023
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 325414: Biological Product (except Diagnostic) Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N95023Q00181
- Notice ID
- 113755233be74b95b506ecad7255f299
Description
The National Center for Advancing Translational Sciences (NCATS) 3D Tissue Bioprinting Laboratory is assembling a portofilio of 3D tissue models in microplate format that can be used for drug testing. In order to accelerate the creation of a ready to use tissue platforms to be able to rapidly respond to health care crisis, like the COVID-19 pandemic, the 3D Tissue Bioprinting laboratory develops its own tissue models, but also looks for opportunities with 3D tissue models that are commercially available, well validated and ready to use. A contractor has indentified by scienitsts at the 3DTBL as a company that produces live fucntional 3D liver microtissues, in a ready to use HTS compatible multiwell plate format. NCATS will use these 3D liver microtissues composed of human primary hepatocytes and a mixture of human primary hepatocyte, liver endothelial cells and kupffer cells to to study viral infectivity, effects of viral infectivity on liver fucntion biomarkers, and effect of anti-viral compounds on viral infection.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95023Q00181- Market Research
- Combined Synopsis
- 4×Market ResearchApr 3, 2023
3D Liver Microtissues Composed of Human Primary Hepatocytes and a Mixture of Human Primary Hepatocyte, Liver Endothelial Cells and Kupffer Cells
- 2×Combined SynopsisCurrentMay 10, 2023
3D Liver Microstissues Composed of Human Primary Hepatocytes and a Mixture of Human Primary Hepatocyte, Liver Endothelial Cells and Kupffer Cells
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95023Q00181
Archive Date
May 15, 2023
Office Address
Bethesda, MD, 20892